All opioid crisis articles

  • Walmart

    ​Walmart to pay $3.1B in nationwide opioid settlement


    Walmart announced it agreed to a $3.1 billion nationwide settlement designed to resolve all the potential state lawsuits it faces for its alleged role in fueling the opioid epidemic.

  • CVS

    Opioid cases against retail pharmacy chains yield compliance lessons


    Two cases involving five retail pharmacy chains winding their way through court foretell a long and costly road ahead for all companies across the pharmaceutical supply chain battling litigation for their alleged roles in fueling the opioid epidemic.

  • McKinsey

    McKinsey to pay $573M for role in opioid epidemic


    McKinsey & Company reached a $573 million settlement with 49 state attorneys general and the District of Columbia related to consulting services it provided to pharmaceutical companies that directly contributed to the opioid epidemic.

  • Walmart

    Compliance called out in Walmart opioid lawsuit


    The Department of Justice alleged many failures by Walmart’s compliance program in its 160-page lawsuit accusing the retailer of playing an active role in fueling the opioid epidemic.

  • Purdue Pharma

    Purdue Pharma case more than an $8B fine


    Compliance officers in the pharmaceutical and healthcare industries should look beyond the $8 billion fine Purdue Pharma received from the DOJ and at the bigger enforcement trend highlighting the need for better oversight in the field.

  • prescriptionpillbottle

    Opioid crisis sparks leadership changes at Purdue Pharma


    In an attempt to distance itself from the opioid epedemic, Purdue Pharma recently made some leadership changes to its board of directors and executive committee, as it battles hundreds of lawsuits across the United States concerning opioid-related deceptive sales and marketing practices that are the focus of U.S. enforcement authorities.